BCR::ABL1 Kinase Domain Variant (Mutation) Status
EPTIS factsheet 146052 | Last revision 2022-06-15 | URL: https://www.eptis.bam.de/pts146052 https://www.eptis.bam.de/pts146052
PT provider | ||||||||||
PT provider | UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping | |||||||||
Based in | United Kingdom | |||||||||
Language(s) | English | |||||||||
Remarks | Please refer to our website for further information: www.ukneqasli.co.uk Qualitative programme, quantitative data submission optional. Educational samples and clinical scenarios may be included. Previously known as BCR-ABL1 Kinase Domain Variant (Mutation) Status | |||||||||
Keywords | ||||||||||
Product groups | ||||||||||
Testing fields |
Biology
Medical analysis |
|||||||||
Technical details | ||||||||||
|
||||||||||
Aims of the PT scheme | ||||||||||
Target group of participants | Participation is open to both UK and international laboratories. | |||||||||
Linked to specific legislation / standards | ISO 17043:2010 ISO 15189:2012 | |||||||||
Additional, subsidiary aims | validation of testing methods | |||||||||
Number of participants | 80 | |||||||||
Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO 17043 |
|||||||||
Operation is commissioned / requested by | ||||||||||
Fees and frequency | ||||||||||
Participation fee | Please contact UK NEQAS LI for details | |||||||||
Regularly operated | Yes (3 per annum (each send-out includes 2 samples)) | |||||||||
Year of first operation | 2013 | |||||||||
Contact details of the PT provider | ||||||||||
Provider | Contact person | |||||||||
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road S10 2QD Sheffield United Kingdom Phone: +44 (0) 114 2673600 Fax: Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk |
Mr Stuart Scott
Phone: +44 (0) 114 2673600 Fax: Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk |